Treatment Archives | American Parkinson Disease Association

What is Parkinson’s
What is Parkinson’s Disease?

This section will help you understand the basics of Parkinson’s disease, how it affects the brain, its symptoms and ongoing research.
Learn about Parkinson’s disease
Living with Parkinson’s
Living with Parkinson’s Disease

Once you are diagnosed with PD, your focus should be on improving your symptoms and maintaining an active and positive lifestyle. This section covers ways to manage symptoms like engaging in regular exercise, eating healthy, exploring medication and treatment options, and assembling your health care team.

Learn More
Resources & Events
Parkinson’s Resource Library

Browse our extensive library of Parkinson’s resources. Watch webinars, download our latest publications, and read articles — all filterable by the topic you would like to learn more about.

Start Browsing
Research
Research

We are committed to scientific research and have been a funding partner in many major Parkinson’s disease scientific breakthroughs, investing more than $65 million in research since 1961. Read about what we fund and explore opportunities for funding.
Learn More
Ways to Give
Ways to Give

We invite you to partner with APDA to provide much needed support that can help improve the quality of life for the 1,000,000+ individuals living with Parkinson’s disease in the US.

Learn More
Find a Chapter

Understanding Stem Cell Therapy in Parkinson’s Disease Treatment

Posted on July 3, 2024February 3, 2025 by Rebecca Gilbert, MD, Ph.D.

Dr. Gilbert gives an update on stem cell therapies for the treatment of Parkinson’s, including profiling a few notable...see more clinical trials underway in 2024

EXCITING PARKINSON’S DISEASE TREATMENT NEWS

Posted on August 28, 2017June 2, 2022 by Phil Franchina

New York, NY, August 28, 2017 – The American Parkinson Disease Association is pleased to share with the Parkinson’s...see more community the arrival of a new medication in the treatment arsenal to address Parkinson’s symptoms. Approved August 24 by the U.S. Food and Drug Administration is GOCOVRI™ (amantadine) developed by Adamas. GOCOVRI is an extended release […]